Skip to main content

Day: August 31, 2021

CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services

UPPSALA, Sweden, Aug. 31, 2021 (GLOBE NEWSWIRE) — CellCarta and Olink Proteomics AB announced today a strategic collaboration to offer Olink® Target 96 & Target 48 to pharmaceutical and biotech customers, advancing targeted protein biomarker quantification in clinical studies. CellCarta is a global leader in precision medicine and with more than 20 years of experience in mass spectrometry the company continues to invest in the field of proteomic biomarkers to better understand diseases and support therapeutic development projects. With the acquisition of the first Olink® Signature Q100 instruments and the collaborative support of Olink, CellCarta becomes the first global clinical CRO to offer the technology. “Complementing our mass spectrometry platforms with the Proximity Extension Assay (PEA) technology from Olink will allow...

Continue reading

First Advantage Set to Explore Hot Topics in Background Screening at 2021 Marketplace Risk Management Conference

ATLANTA, Aug. 31, 2021 (GLOBE NEWSWIRE) —WHO: First Advantage (NASDAQ: FA), a leading global provider of technology solutions for screening, verifications, safety and compliance related to human capital   WHAT: Will co-present two sessions during the 2021 Marketplace Risk Management Conference.   WHEN: The event will take place Tuesday, September 14 and Wednesday, September 15, 2021.“Creating a Culture of Safety in a Gig Economy”—co-presented with Lyft—is scheduled for September 15 at 3:55 p.m. PT.“Background Check Round Robin: Hot Topics, Current Trends, Regulatory Issues, Platform Mistakes” is on the agenda for September 15 at 1:35 p.m. PT.   WHERE: Bespoke Events845 Market StreetSan Francisco, Calif. To register, visit https://www.marketplacerisk.com/conference.DETAILS: Creating and maintaining a culture...

Continue reading

Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2 with Health Canada Consent

McMaster University researchers using MediPharm Labs’ CBD50 formula and a CBD:THC 10:2 formulation, which has the same cannabinoid ratio as MediPharm Labs’ CBD25:, have received a No Objection Letter from Health Canada to begin recruiting human subjects for a placebo-controlled trial using cannabis- oil for treatment of insomnia in major depressive disorder.Among those with depression, 75% have difficulty falling or staying asleep – according to John Hopkins Medicine. MediPharm Labs and the McMaster Research Team hope CBD50 and/or CBD10:2 provides these patients with relief from this condition.BARRIE, Ontario, Aug. 31, 2021 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in cannabis, is pleased to announce that the...

Continue reading

CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services

UPPSALA, Sweden, Aug. 31, 2021 (GLOBE NEWSWIRE) — CellCarta and Olink Proteomics AB announced today a strategic collaboration to offer Olink® Target 96 & Target 48 to pharmaceutical and biotech customers, advancing targeted protein biomarker quantification in clinical studies. CellCarta is a global leader in precision medicine and with more than 20 years of experience in mass spectrometry the company continues to invest in the field of proteomic biomarkers to better understand diseases and support therapeutic development projects. With the acquisition of the first Olink® Signature Q100 instruments and the collaborative support of Olink, CellCarta becomes the first global clinical CRO to offer the technology. “Complementing our mass spectrometry platforms with the Proximity Extension Assay (PEA) technology from Olink will allow...

Continue reading

Genuine, high-quality sauna stones ensure a safe sauna enjoyment – Harvia acquires Sauna-Eurox

Harvia_Sauna-Eurox_StonesHarvia_Sauna-Eurox_StonesHarvia Plc, Press release, 31 August 2021 at 02:00 p.m. EETHarvia Plc has signed and closed an agreement to acquire Sauna-Eurox Oy. Together, the parties will continue to develop and expand the sauna stone business. Concurrently, Harvia also acquires Sauna-Eurox Oy’s sister company Parhaat Löylyt Oy. Sauna-Eurox, founded in 1991 and based in Luvia, Western Finland, is one of the world’s largest suppliers of safe and durable sauna stones. The company has over 30 years of experience of different stone varieties, their thermal durability, and their use as sauna stones. The company’s stones are purchased from responsible sources in Finland, raw materials stemming often from valuable side streams of larger stone materials used in the construction industry. Consolidated revenue...

Continue reading

VectivBio to Acquire Comet Therapeutics and Host R&D Day

– Acquisition of Innovative Small Molecule Platform Significantly Expands Rare Disease Pipeline –– VectivBio to Host R&D Day on September 21, 2021- BASEL, Switzerland, Aug. 31, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced that it will acquire Comet Therapeutics, Inc., a privately held company that has been developing drugs to address previously untreatable Inherited Metabolic Diseases. This acquisition significantly expands VectivBio’s rare disease pipeline.The novel and proprietary CoMET platform is aimed at addressing Inherited Metabolic Diseases (IMDs) with deficit of energy metabolism and depletion of functional Coenzyme A (“CoA”) IMDs affect...

Continue reading

KULR Technology Group Sets September 2021 Financial Conference Schedule

SAN DIEGO, Aug. 31, 2021 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leading developer of next-generation lithium-ion battery safety and thermal management technologies, is scheduled to participate at the following virtual financial conferences in September 2021: 10th Annual Gateway ConferencePresenting Thursday, September 9, 2021, at 1:00 p.m. Eastern time (one-on-one meetings September 8-9, 2021)Executives: Michael Mo, CEOWebcast H.C. Wainwright 23rd Annual Global Investment ConferencePresenting Monday, September 13, 2021, at 7:00 a.m. Eastern time (one-on-one meetings September 13-15, 2021)Executives: Michael Mo, CEOParticipants can register here Benzinga Electric Vehicles ConferencePresenting Wednesday, September 22, 2021, at 1:35 p.m. Eastern timeExecutives:...

Continue reading

GREYSTONE LOGISTICS, INC. REPORTS RESULTS OF OPERATIONS FOR THE YEAR ENDED MAY 31, 2021

Tulsa, OK, Aug. 31, 2021 (GLOBE NEWSWIRE) — GREYSTONE LOGISTICS, INC. (OTCQB:GLGI). Tulsa-based Greystone Logistics, Inc. reports earnings for the fiscal year ended May 31, 2021. Greystone recorded net income available to common stockholders (net income less preferred dividends and income from non-controlling interests) for fiscal year 2021 of $3,030,165, or $0.11 per share, compared to $4,301,585, or $0.15 per share, in fiscal year 2020. EBITDA for fiscal year 2021 was $12,080,272 compared to $12,152,793 in 2020. Greystone’s net income was $3,625,526 in fiscal year 2021 compared to $4,962,570 in fiscal year 2020 noting that net income in fiscal year 2020 included the effect of a decrease in the valuation allowance for net operating losses of approximately $1.4 million. Sales for the fiscal year ended May 31, 2021 were $64,925,059...

Continue reading

Dada to Announce Second Quarter 2021 Unaudited Financial Results on September 7, 2021

SHANGHAI, China, Aug. 31, 2021 (GLOBE NEWSWIRE) — Dada Nexus Limited (“Dada” or the “Company”) (NASDAQ: DADA), China’s leading local on-demand delivery and retail platform, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2021, on Tuesday, September 7, 2021, after the close of U.S. markets. The Company will host a conference call to discuss the earnings at 9:00 p.m. Eastern Time on Tuesday, September 7, 2021 (9:00 a.m. Beijing time on Wednesday, September 8, 2021). Please register in advance of the conference using the link provided below and dial in 10 minutes prior to the call, using participant dial-in numbers, Direct Event passcode and unique registrant ID which would be provided upon registering. You will be automatically linked to the live call after completion of...

Continue reading

GBT Evaluates Developing a Driver Monitoring System Based on Its Wireless Movement and Position Detection Technology

SAN DIEGO, Aug. 31, 2021 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”), evaluates developing a driver monitoring system based on its wireless movement and position detection technology, internal project code name Apollo. Apollo is an intelligent method and system to detect motion-based radio waves. An AI system controls radio wave transmission and analyzes the reflected information to construct 2D and 3D images including real time movement. The system, once developed also can potentially detect human’s vitals like heart rate, breathing rhythm and more. GBT is investigating applying this technology as a vehicle’s driver monitoring system. Statistics show that more than 90% of road accidents are caused by driver error (European survey – European New Car Assessment Program (Euro NCAP)....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.